VR-based Remote Rehabilitation for Pediatric ABI

Sponsor
Libra At Home LTD (Industry)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05052905
Collaborator
Alyn Pediatric & Adolescent Rehabilitation Hospital (Other)
8
1
1
13.5
0.6

Study Details

Study Description

Brief Summary

The primary objective of this study is to evaluate the feasibility and effectiveness of an at-home program of VR-based vestibular and oculomotor rehabilitation on improving postural stability, ocular motility and activities of daily living for children with mild to severe ABI

Condition or Disease Intervention/Treatment Phase
  • Device: LibraVR
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
8 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Virtual Reality Based Rehabilitation of Vestibular and Oculomotor Function for Pediatric ABI in a Home Setting
Actual Study Start Date :
Oct 15, 2021
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Study

Exercises

Device: LibraVR
LibraVR is a standalone VR-based rehabilitation software for use in physiotherapy. It is designed to work with standard off-the-shelf hardware that is tested and approved for use in conjunction with the software. LibraVR system consists of the software (LibraVR Clinic) running on a PC (database of patients, creation of protocols, uploading protocols to mobile), and the LibraVR Mobile APP that runs on commercial mobile smartphones embedded in a lightweight cardboard or plastic VR viewer that the child wears as they would eyeglasses. The software displays a range of immersive VR exercises.

Outcome Measures

Primary Outcome Measures

  1. Vestibular Oculomotor Motor Screening (VOMS) [6 months]

    Symptoms scoring from 0 (none) to 10 (severe)

  2. Pediatric Vestibular Symptom Questionnaire (PVSQ) [6 months]

    Score ranging from 0 (never) to 33 (most of the time) with a 4-Likert scale

  3. Convergence Insufficiency Symptom Survey (CISS) [6 months]

    Score ranging from 0 (never) to 56 (Always) with a 5-Likert scale

  4. Dizziness Handicap Inventory (DHI) [6 months]

    Score ranging from 0 (none) to 100 (severe) with a 3-Likert scale

  5. Dizziness Handicap Inventory for patients caregivers (DHI-PC) [6 months]

    Score ranging from 0 (none) to 100 (severe) with a 3-Likert scale

  6. Pediatric Quality of Life Inventory (PEDSQL) [6 months]

    Score ranging from 0 (worst) to 100 (best) with a 5-Likert scale

  7. Modified Clinical Test of Sensory Interaction in Balance (mCTSIB) [6 months]

    Time score ranging from 0 (unable to complete) to 120 (completed successfully) in one of three 30-seconds trials and four conditions

  8. Berg Balance Scale (Berg) [6 months]

    Score ranging from 0 (lowest level of function) to 56 (highest level of function) with a 5-Likert scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • They are ALYN patients undergoing physiotherapy for mild to severe ABI;

  • They experience symptoms of vestibular function such as vertigo, postural instability, or impaired ocular motility;

  • They are between the ages of 8 and 18;

  • The time since injury/event is between 10 days and 1 year after the injury/event;

  • They are able to maintain stable and dynamic positioning of the head;

  • They able to walk with or without assistive equipment, or use a wheelchairs with no need for head support, defined by a LSS (level of sitting scale) score of 3 or greater (scale range: 1-8);

  • Are able to understand basic instructions;

  • Have sufficient visual acuity and visual field to identify and track mid-size objects on a screen.

Exclusion Criteria:
  • Psychological, neurological or cognitive disorders which could impede participation, such as a history of epileptic seizures;

  • Untreated benign paroxysmal positional vertigo (BPPV);

  • Are in early post-operative stages (to avoid risk of bleeding or cerebrospinal fluid leak);

  • Hearing impairment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 ALYN Hospital Pediatric and Adolescent Rehabilitation Center Jerusalem Israel

Sponsors and Collaborators

  • Libra At Home LTD
  • Alyn Pediatric & Adolescent Rehabilitation Hospital

Investigators

  • Principal Investigator: Naomi Gefen, ALYN Hospital Pediatric and Adolescent Rehabilitation Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Libra At Home LTD
ClinicalTrials.gov Identifier:
NCT05052905
Other Study ID Numbers:
  • 041-21
First Posted:
Sep 22, 2021
Last Update Posted:
Aug 16, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Libra At Home LTD
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 16, 2022